|
US3992522A
(en)
|
1973-01-24 |
1976-11-16 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Temperature-sensitive recombinant mutant viruses and a process for producing same
|
|
US4071618A
(en)
|
1974-09-03 |
1978-01-31 |
Research Foundation For Microbial Diseases Of Osaka University |
Process for preparing virus disease live vaccines
|
|
JPS57136528A
(en)
|
1981-02-09 |
1982-08-23 |
Hayashibara Biochem Lab Inc |
Preparation of viral vaccine
|
|
CH652145A5
(de)
|
1982-01-22 |
1985-10-31 |
Sandoz Ag |
Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
|
|
US4634666A
(en)
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
|
US4752473A
(en)
*
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5840520A
(en)
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
|
US5665362A
(en)
|
1990-09-25 |
1997-09-09 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
|
WO1993021306A1
(en)
|
1992-04-14 |
1993-10-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Genetically engineered attenuated viruses
|
|
IL105456A
(en)
|
1992-04-21 |
1996-12-05 |
American Home Prod |
Vaccines of attenuated respiratory syncytial virus
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
US5716821A
(en)
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
|
WO1996010400A1
(en)
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
|
US5756341A
(en)
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
|
US6146873A
(en)
|
1994-11-10 |
2000-11-14 |
Baxter Aktiengesellschaft |
Production of orthomyxoviruses in monkey kidney cells using protein-free media
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
US5690937A
(en)
|
1995-06-05 |
1997-11-25 |
Aviron |
Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
CA2230033C
(en)
|
1995-09-27 |
2010-01-26 |
Peter L. Collins |
Production of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
DE69634904T2
(de)
|
1995-10-31 |
2006-05-18 |
Dnavec Research Inc., Tsukuba |
Negativstrand rna virus mit selbständiger replikationsaktivität
|
|
CN1143892C
(zh)
|
1995-11-01 |
2004-03-31 |
株式会社载体研究所 |
重组仙台病毒
|
|
US6090391A
(en)
|
1996-02-23 |
2000-07-18 |
Aviron |
Recombinant tryptophan mutants of influenza
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
BR9712138A
(pt)
|
1996-09-27 |
2000-01-18 |
American Cyanamid Co |
Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
|
|
DE69842165D1
(de)
|
1997-05-23 |
2011-04-21 |
Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services |
Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
|
|
ES2287977T3
(es)
|
1997-07-11 |
2007-12-16 |
Yale University |
Rabdovirus con cubiertas rediseñadas.
|
|
JP2001517448A
(ja)
|
1997-09-19 |
2001-10-09 |
アメリカン・サイアナミド・カンパニー |
弱毒化呼吸合胞体ウイルス
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
EP1035209A1
(en)
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
|
EP1185615B1
(en)
|
1999-04-06 |
2007-08-01 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses for vaccines and gene therapy
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
RU2280690C2
(ru)
|
2000-03-02 |
2006-07-27 |
Полимун Сайнтифик Иммунбиологише Форшунг Гмбх |
Рекомбинантные вирусы гриппа а
|
|
PL205955B1
(pl)
|
2000-04-28 |
2010-06-30 |
St Jude Childrens Res Hospital |
Układ oparty na minimalnej liczbie plazmidów do wytwarzania infekcyjnych wirusów RNA o ujemnej nici, komórka gospodarza zawierająca taki układ, sposób wytwarzania wiriona wirusa RNA o ujemnej nici, sposób wytwarzania atenuowanego wirusa RNA o ujemnej nici, sposób wytwarzania zakaźnego wirusa o ujemnej nici do stosowania w szczepionkach i zastosowanie układu opartego na minimalnej liczbie plazmidów
|
|
ES2327103T3
(es)
|
2000-09-25 |
2009-10-26 |
Polymun Scientific Immunbiologische Forschung Gmbh |
Vacuna viva de influenzavirus y procedimiento de fabricacion.
|
|
USPP15035P3
(en)
*
|
2001-06-27 |
2004-07-27 |
Marko Zaninovich, Inc. |
Grapevine ‘12-76-71’
|
|
KR100600988B1
(ko)
*
|
2002-03-13 |
2006-07-13 |
주식회사 엘지생명과학 |
Ｄｎａ 면역화에서 인플루엔자 ｎｐ 유전자 ｄｎａ를 함께투여하여 면역반응을 증가시키는 방법
|
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
EP1499348B1
(en)
*
|
2002-04-26 |
2014-10-01 |
MedImmune, LLC |
Method for producing infectious influenza b virus in cell culture
|
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
US7037707B2
(en)
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
EP2902484A1
(en)
|
2004-05-25 |
2015-08-05 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|
|
WO2006049061A1
(ja)
|
2004-11-01 |
2006-05-11 |
Eiken Kagaku Kabushiki Kaisha |
Ｈ５型又はｈ７型トリインフルエンザウイルスの検出方法
|
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
|
RU2315101C2
(ru)
*
|
2006-01-10 |
2008-01-20 |
ГУ "Научно-исследовательский институт экспериментальной медицины "Российской Академии медицинских наук (ГУ НИИЭМ РАМН) |
Вакцинный штамм вируса гриппа а/17/калифорния/ 04/6 (н3n2) и донор аттенуации а/ленинград/134/17/к7/57 (н2n2) для его получения
|
|
JP2010500034A
(ja)
*
|
2006-08-09 |
2010-01-07 |
メッドイミューン バクシーンズ，インコーポレイティド |
インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
|
|
US8084594B2
(en)
*
|
2007-07-13 |
2011-12-27 |
The United States Of America As Represented By The Secretary Of Agriculture |
H2N3 influenza A viruses and methods of use
|
|
EP2396033B1
(en)
|
2009-02-12 |
2016-09-28 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|